EXTAVIA
EXTAVIA
Discontinued
DIN Number
02337819
Drug Class
Human
Market Date
May 5, 2010
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02337819
AIG Number0152204001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L03AB08 INTERFERON BETA-1B
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
INTERFERON BETA-1BActive
Strength: 0.3 MG / VIAL
Monograph: INTERFERON BETA-1B